Leading brokers name 3 ASX shares to sell today

Leading brokers have named Bubs Australia Ltd (ASX:BUB) and these ASX shares as sells this week. Here's why they are bearish…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Monday I looked at three ASX shares that brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below. Here's why these brokers are bearish on these ASX shares:

Business man marking Sell on board and underlining it

Image Source: Getty Images

Bubs Australia Ltd (ASX: BUB)

According to a note out of Citi, its analysts have retained their sell rating and 35 cents price target on this infant formula company. This follows the release of a mixed third quarter update last week. The broker continues to believe that Bubs is in a difficult spot due to challenging market conditions in China which is seeing domestic players outperforming. Especially given how small its brand is. Furthermore, it feels that China's declining birth rate means the market could contract in the near future. The Bubs share price is trading at 40 cents today.

Paradigm Biopharmaceuticals Ltd (ASX: PAR)

A note out of Morgans reveals that its analysts have retained their reduce rating and $1.69 price target on this biopharmaceutical company's shares. According to the note, the broker wasn't surprised to see the US FDA put Paradigm's investigational new drug (IND) application on hold. Morgans believes that a decision could be months away, which will lead to further cash burn and uncertainty. The broker has previously stated that it sees risk to the viability of the company's osteoarthritis drug as a commercial asset. The Paradigm share price is fetching $2.33 today.

Premier Investments Limited (ASX: PMV)

Analysts at Goldman Sachs have retained their sell rating and $20.20 price target on this retail conglomerate's shares. This follows an update on its JobKeeper payment and guidance for FY 2021. According to the note, Premier Investments' earnings before interest and tax guidance of $318 million is largely in line with its estimates. However, this doesn't change its view on the company. With Goldman expecting its earnings to fall materially in FY 2022 and then remain flat into FY 2023, it feels its shares are expensive at the current level. The Premier Investments share price is trading at $26.12 this afternoon.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of BUBS AUST FPO. The Motley Fool Australia owns shares of and has recommended Premier Investments Limited. The Motley Fool Australia has recommended BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Up 73%! 3 reasons I'd still buy Mineral Resources shares today

A leading expert forecasts more outperformance from Mineral Resources' surging shares.

Read more »

Friends in a 4WD.
Broker Notes

Following its results, Macquarie is tipping 80% upside for this ASX 300 stock

This parts supplier appears primed for share price growth.

Read more »

Happy mum and dad with daughter smiling on couch after relocation to new home.
Broker Notes

After crashing 19% this broker says Life360 shares are a buy

Investors should consider buying the dip after yesterday's sell-off.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on NAB shares

A leading expert forecasts growing headwinds for NAB shares. But why?

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Bell Potter names 3 ASX shares to buy after results

The broker is bullish on these names. Here's what it is recommending.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Up 59%! Here are 3 reasons I'd still buy Newmont shares today

A leading expert forecasts more outperformance from gold mining giant Newmont.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Broker Notes

After falling 33% over two days, a huge 77% rebound for this ASX real estate stock is tipped

A shock from a childcare tenant has this stock under pressure.

Read more »

Young worried man looking at phone.
Broker Notes

Are Austal shares a buy, hold or sell after soaring 17% yesterday?

What's next for this defence stock?

Read more »